Prognostic Relevance of Changes in Exercise Test Variables in Pulmonary Arterial Hypertension

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Groepenhoff, Herman ^a   Vonk Noordegraaf, Anton ^a   van de Veerdonk, Mariëlle C ^a   Boonstra, Anco ^a   Westerhof, Nico ^a   Bogaard, Harm J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE;

ADULT; AEROBIC CAPACITY; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR MAGNETIC RESONANCE; FEMALE; FOLLOW UP; HEART RATE; HEART RIGHT VENTRICLE EJECTION FRACTION; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE SCANNER; OXYGEN CONSUMPTION; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL;

ADULT; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; ROC CURVE; TREATMENT OUTCOME; WALKING;

EID: 84883549882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072013     Document Type: Article

References (28)

1. Sun XG, Hansen JE, Oudiz RJ, Wasserman K, (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104: 429-435. doi:10.1161/hc2901.093198. PubMed: 11468205.
2. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, et al. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30: 2493-2537. doi:10.1093/eurheartj/ehp297. PubMed: 19713419.
3. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, et al. (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119: 2250-2294. doi:10.1161/CIRCULATIONAHA.109.192230. PubMed: 19332472.
4. Wensel R, Opitz CF, Anker SD, Winkler J, Höffken G, et al. (2002) Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 106: 319-324. doi:10.1161/01.CIR.0000022687.18568.2A. PubMed: 12119247.
5. Groepenhoff H, Vonk-Noordegraaf A, Boonstra A, Spreeuwenberg MD, Postmus PE, et al. (2008) Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 40: 1725-1732. doi:10.1249/MSS.0b013e31817c92c0. PubMed: 18799981.
6. Deboeck G, Scoditti C, Huez S, Vachiéry JL, Lamotte M, et al. (2012) Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension. Eur Respir J 40: 1410-1419. doi:10.1183/09031936.00217911. PubMed: 22441747.
7. Nickel N, Golpon H, Greer M, Knudsen L, Olsson K, et al. (2012) The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 39: 589-596. doi:10.1183/09031936.00092311. PubMed: 21885392.
8. Provencher S, Hervé P, Sitbon O, Humbert M, Simonneau G, et al. (2008) Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J 32: 393-398. doi:10.1183/09031936.00009008. PubMed: 18417516.
9. Provencher S, Sitbon O, Humbert M, Cabrol S, Jaïs X, et al. (2006) Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J 27: 589-595. doi:10.1093/eurheartj/ehi728. PubMed: 16431875.
10. McLaughlin VV, Shillington A, Rich S, (2002) Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106: 1477-1482. doi:10.1161/01.CIR.0000029100.82385.58. PubMed: 12234951.
11. Oudiz RJ, Midde R, Hovenesyan A, Sun XG, Roveran G, et al. (2010) Usefulness of right-to-left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension. Am J Cardiol 105: 1186-1191. doi:10.1016/j.amjcard.2009.12.024. PubMed: 20381675.
12. Ross RM, (2003) ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167: 1451. doi:10.1164/ajrccm.167.10.952. PubMed: 12738602.
13. Tabet JY, Beauvais F, Thabut G, Tartière JM, Logeart D, et al. (2003) A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure. Eur J Cardiovasc Prev Rehabil 10: 267-272. doi:10.1097/00149831-200308000-00008. PubMed: 14555881.
14. Beaver WL, Wasserman K, Whipp BJ, (1986) A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60: 2020-2027. PubMed: 3087938.
15. Sun XG, Hansen JE, Oudiz RJ, Wasserman K, (2002) Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation 105: 54-60. doi:10.1161/hc0102.101509. PubMed: 11772876.
16. van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, et al. (2011) Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 58: 2511-2519. doi:10.1016/j.jacc.2011.06.068. PubMed: 22133851.
17. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, et al. (2000) Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161: 487-492. doi:10.1164/ajrccm.161.2.9906015. PubMed: 10673190.
18. Provencher S, Chemla D, Hervé P, Sitbon O, Humbert M, et al. (2006) Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension. Eur Respir J 27: 114-120. doi:10.1183/09031936.06.00042705. PubMed: 16387943.
19. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, et al. (2004) Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 110: 1308-1312. doi:10.1161/01.CIR.0000140724.90898.D3. PubMed: 15337703.
20. Ciarka A, Doan V, Velez-Roa S, Naeije R, van de Borne P, (2010) Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med 181: 1269-1275. doi:10.1164/rccm.200912-1856OC. PubMed: 20194810.
21. Schwaiblmair M, Faul C, von Scheidt W, Berghaus TM, (2012) Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension. BMC Pulm Med 12: 23. doi:10.1186/1471-2466-12-23. PubMed: 226763041471-2466-12-23.
22. Peacock AJ, Naeije R, Galiè N, Rubin L, (2009) End-points and clinical trial design in pulmonary arterial hypertension: have we made progress? Eur Respir J 34: 231-242. doi:10.1183/09031936.00107108. PubMed: 19567606.
23. Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, et al. (2004) Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169: 441-447. doi:10.1164/rccm.200307-957OC. PubMed: 14630619.
24. Oudiz RJ, Roveran G, Hansen JE, Sun XG, Wasserman K, (2007) Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Eur J Heart Fail 9: 917-921. doi:10.1016/j.ejheart.2007.06.013. PubMed: 17707133.
25. Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, et al. (2003) Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 41: 2119-2125. doi:10.1016/S0735-1097(03)00463-7. PubMed: 12821234.
26. Wax D, Garofano R, Barst RJ, (1999) Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension. Chest 116: 914-920. doi:10.1378/chest.116.4.914. PubMed: 10531153.
27. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, et al. (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334:296-302.
28. Ciarka A, Cuylits N, Vachiery JL, Lamotte M, Degaute JP, et al. (2006) Increased peripheral chemoreceptors sensitivity and exercise ventilation in heart transplant recipients. Circulation 113: 252-257. doi:10.1161/CIRCULATIONAHA.105.560649. PubMed: 16401774.